RACHAEL TRIDENTE: Open Payments
NPI 1639417330 · ATLANTIC CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 40 payments from 9 companies in 2025. Trend: 2023 $567 · 2024 $624 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $419 |
| Paratek Pharmaceuticals, Inc. | 5 | $81 |
| La Jolla Pharmaceutical Company | 3 | $62 |
| Shionogi Inc | 3 | $53 |
| ViiV Healthcare Company | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Insmed, Inc. | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: AVYCAZ, NUZYRA, DALVANCE, TEFLARO, Fetroja, MAVYRET, XACDURO, RUKOBIA.
Industry payments across NJ — which companies pay providers there.
